GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ferozsons Laboratories Ltd (KAR:FEROZ) » Definitions » Retained Earnings

Ferozsons Laboratories (KAR:FEROZ) Retained Earnings : ₨7,314 Mil (As of Sep. 2024)


View and export this data going back to 1960. Start your Free Trial

What is Ferozsons Laboratories Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Ferozsons Laboratories's retained earnings for the quarter that ended in Sep. 2024 was ₨7,314 Mil.

Ferozsons Laboratories's quarterly retained earnings increased from Mar. 2024 (₨6,838 Mil) to Jun. 2024 (₨7,040 Mil) and increased from Jun. 2024 (₨7,040 Mil) to Sep. 2024 (₨7,314 Mil).

Ferozsons Laboratories's annual retained earnings increased from Jun. 2022 (₨6,100 Mil) to Jun. 2023 (₨6,290 Mil) and increased from Jun. 2023 (₨6,290 Mil) to Jun. 2024 (₨7,040 Mil).


Ferozsons Laboratories Retained Earnings Historical Data

The historical data trend for Ferozsons Laboratories's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ferozsons Laboratories Retained Earnings Chart

Ferozsons Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,644.63 5,712.63 6,100.33 6,289.98 7,040.05

Ferozsons Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,070.84 6,678.16 6,838.11 7,040.05 7,314.02

Ferozsons Laboratories Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Ferozsons Laboratories  (KAR:FEROZ) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Ferozsons Laboratories Business Description

Traded in Other Exchanges
N/A
Address
5.K.M - Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.

Ferozsons Laboratories Headlines

No Headlines